PCG Wealth Advisors, LLC

SEC CIK: 0001905393
Latest filing: Aug 3, 2026

SEC filings (opens in a new tab)

ZYNE holding history

Zynerba Pharmaceuticals, Inc. in every 13F filed by PCG Wealth Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ZYNE overview All 13F holders of ZYNE Full Q2 2026 holdings

Shares (Q4 2022): 0; Sold out in Q4 2022
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q4 2021

Holdings of ZYNE by PCG Wealth Advisors, LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q4 2022	0	$0	0.0%	−15,200−100.0%	Sold out	Holders
Q3 2022	15,200	$12.0K	<0.1%	+15,200	New	Holders
Q1 2022	0	$0	0.0%	−11,900−100.0%	Sold out	Holders
Q4 2021	11,900	$34.0K	<0.1%	–	No prior filing	Holders